September 4th 2025
The therapy from Boehringer Ingelheim provides protection against porcine circovirus type 2.
FDA scraps 12-year-old petition to pull antibiotic approvals for food animals
January 1st 2012Rockville, Md. - Twelve years after filing a petition calling for the phase-out of non-medical uses of antibiotics in food animals, the U.S. Food and Drug Administration (FDA) recently denied these petitions by saying withdrawing approvals for certain antimicrobail uses in food animals would consume too much of the agency's time and resources.
Abdominal discomfort in llamas and alpacas: causes and clinical characteristics (Proceedings)
November 1st 2010The subject of abdominal pain in camelids has been addressed a number of times over the years, with the discussion becoming progressively more detailed as we gain experience with these species. We were truly learning from scratch, as the South American approach (hands off and deal with the consequences) was generally unsuitable to North American tastes.
Antimicrobial therapy: regimen selection (Proceedings)
November 1st 2010Traditionally, we have assumed that if a bacterial pathogen is "susceptible" to an antimicrobial, we just use the dose on the bottle or in a formulary, and the infection will be eliminated. The increasing incidence of "resistant" pathogens, i.e., pathogens requiring high concentrations of antimicrobials such that they become untreatable, has focused attention on identifying ways to reduce the selection for resistant organisms.
Antimicrobial therapy: interpreting susceptibility results (Proceedings)
November 1st 2010The design of antimicrobial regimens is addressed in the next section in these proceedings ("Antimicrobial Therapy: Regimen Design"), but the concepts within regimen design related to determining the concentration of drug required to inhibit growth of bacterial pathogens deserve a more thorough discussion. Antimicrobial susceptibility testing must not be viewed as a black box into which a veterinarian places a clinical sample of an infected site and receives a "yes" or "no" from the diagnostic laboratory.
Antimicrobials for bovine respiratory disease (Proceedings)
November 1st 2010Bovine respiratory disease complex includes bacterial components, which cause the classic clinical signs of lethargy, depression, and fever, with variable nasal discharge, cough, or other signs. This bacterial component of BRD (most commonly Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis) may be treated with antimicrobial drugs designed to kill or inhibit the growth of the pathogenic bacteria.
Accountability of dairy welfare, judicious use of drugs, and dairy management (Proceedings)
August 1st 2010Opponents of food animal use rhetoric and disturbing images to incriminate lack of welfare, criticize drug usage, and incriminate modern care practices if they weren't the same method of care as in the past. They have an audience of consumers that have little or no knowledge of food animal care.
Antimicrobial therapy: interpreting susceptibility results (Proceedings)
August 1st 2010The design of antimicrobial regimens is addressed in the next section in these proceedings, but the concepts within regimen design related to determining the concentration of drug required to inhibit growth of bacterial pathogens deserve a more thorough discussion.